医学
利胆的
熊去氧胆酸
原发性硬化性胆管炎
肝移植
胃肠病学
内科学
原发性胆汁性肝硬化
碱性磷酸酶
移植
肝硬化
胆汁酸
疾病
酶
生物化学
化学
作者
W.H. Wheless,Mark W. Russo
标识
DOI:10.1016/j.cld.2023.07.008
摘要
Primary sclerosing cholangitis is a progressive cholestatic liver disease that causes stricturing of the intra and extrahepatic bile ducts that can lead to cirrhosis and end stage liver disease . Effective medical therapy has been elusive, but a course of ursodeoxycholic acid may be prescribed at doses of 17-23 mg/kg/day for up to a year to determine if a reduction in serum alkaline phosphatase is observed. A number of drugs are under investigation, including FXR agonists with choleretic and antimicrobial properties . Liver transplantation for PSC has one of the highest survival rates, but recurrent PSC is seen in up to 25% of recipients.
科研通智能强力驱动
Strongly Powered by AbleSci AI